| Financial Year |
March 31 2023 |
| Monetary Funds |
825,908,444.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,797,235,315.55 |
| Accounts Receivable |
2,672,416,672.25 |
| Advances to Suppliers |
194,521,616.59 |
| Other Receivables |
20,313,900.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,579,993,817.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,602,266.89 |
| Total Current Assets |
9,213,821,238.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
42,135.52 |
| Long-term Equity Investment |
11,700,984.74 |
| Investment Properties |
67,207,328.91 |
| Fixed Assetes |
2,484,972,296.67 |
| Under-construction Projects |
776,536,021.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
182,983,999.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,459,001.44 |
| Deferred Income Tax Assets |
83,533,680.96 |
| Other Non-Current Assets |
2,294,661.50 |
| Sub-Total of Non-Current Assets |
3,715,217,260.90 |
| Total Assets |
12,929,038,499.74 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
282,057,200.00 |
| Accounts Payable |
1,613,881,002.26 |
| Accounts Received In Advance |
3,911.28 |
| Employee Compensation Payable |
45,927,583.11 |
| Taxes Payable |
51,713,868.05 |
| Interest Payable |
-- |
| Dividend Payable |
66,664,775.86 |
| Other payables |
98,634,230.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
500,405,054.89 |
| Other Current Liabilities |
1,153,524,682.79 |
| Sub-Total of Current Liabilities |
4,052,623,697.52 |
| Long-term Loans |
943,000,000.00 |
| Bonds Payable |
720,599,039.73 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,041,730.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,012,267,928.53 |
| Total Liabilities |
6,064,891,626.05 |
| Paid-In Capital(Or Share Stock) |
477,777,539.00 |
| Capital Surplus |
4,291,632,213.36 |
| Surplus Reserve |
328,862,173.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,227,385,758.63 |
| Minority Stockholder's Interest |
532,997,822.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,331,149,051.32 |
| Owner's Equity（Stockholder's Equity） |
6,864,146,873.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,929,038,499.74 |
